Advanced Enzyme Technologies Ltd (ADVENZYMES)

NSE · Healthcare · Pharmaceuticals & Biotechnology · Biotechnology

₹263.55

As of 30 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close ₹263.55 on 30 Oct 2026. The share price traded between ₹246.80 and ₹419.00 (intraday) over the last 12 months.

The closes as a table

DateClose

Key figures

1-year range (intraday)

Last close ₹263.55

Low ₹246.80High ₹419.00

Market cap₹2,899 crorelast close × shares
P/E17.8on reported profit, last four quarters, consolidated
Net profit₹172 crlast 12 months
Return on equity10.2%year to Mar 2026
EBITDA margin31%year to Mar 2026
Debt to equity0.02year to Mar 2026
Net margin23.3%year to Mar 2026
Dividend yield0.51%last 12 months

P/E 17.8 is on the last four reported quarters. Dec 2025 had other income of ₹20 crore against a median of ₹8 crore in the other quarters shown, so that income is in the earnings behind the figure.

Price trend

Revenue and profit

RevenueNet profit₹ crore
0200400600800
YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue529541624637746
Net profit124104137134174
EBITDA margin38%29%33%31%31%
Borrowings3534473932

₹ crore. Over three years, compounded: revenue grew 11.3% a year, net profit grew 18.7% a year.

Recent filings

Questions about Advanced Enzyme Technologies Ltd

What is Advanced Enzyme Technologies Ltd's market value?

Advanced Enzyme Technologies Ltd's market value is ₹2,899 crore as of 30 Oct 2026 close: the last close times the shares in issue. Its P/E is 17.8, the last close over earnings per share for the last four reported quarters.

When are Advanced Enzyme Technologies Ltd's next results?

Advanced Enzyme Technologies Ltd's next results are listed for 31 Oct 2026 (the exchange's notice: Financial Results). Dates are as the company announced them, on the list of 30 Oct 2026.

Who are Advanced Enzyme Technologies Ltd's largest named shareholders?

In the shareholding pattern for the quarter ended 30 Sep 2026, the largest named holders above 1% were: Vasant Rathi (promoter group) 26.87%; Orbimed Asia III Mauritius FVCI Limited (public) 12.15%; Nalanda India Equity Fund Limited (public) 8.38%. Percentages are of all shares.

Go further with ADVENZYMES

Free to start: test a trading idea on ADVENZYMES's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Same industry

The largest companies in the same industry (Biotechnology), by market value.

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out